Results 161 to 170 of about 2,612,016 (174)
Some of the next articles are maybe not open access.
Detoxification of Crystalline Botulinum Type A Toxin
The Journal of Immunology, 1947Summary Botulinum Type A toxoid has been prepared from crystalline toxin by the addition of formaldehyde. The most active preparation consisted of one component electrophoretically, immunized mice in a dose containing 0.01γ of toxoidnitrogen and was 2400 times more active antigenically than crude toxoid on the basis of nitrogen-content.
G A, HOTTLE, A, ABRAMS
openaire +2 more sources
Pharmacology and immunology of botulinum toxin type A
Clinics in Dermatology, 2003The utility of botulinum neurotoxins as therapeutic and esthetic agents depends on their ability to inhibit neurotransmitter release from selected neurons, remain localized at the site of injection, and evade the body's immunologic defenses. The clinical correlates of these actions, respectively, are efficacy, safety, and a low rate of antibody ...
openaire +3 more sources
Botulinum toxin type A for the treatment of migraine
Expert Opinion on Pharmacotherapy, 2006Migraine is a common and debilitating disorder that often requires prophylactic therapy, particularly for those migraine patients who meet the diagnostic criteria for chronic daily headache (chronic migraine). Existing prophylactic treatments for migraine are inadequate for many patients due to their modest efficacy and/or systemic side effects ...
openaire +3 more sources
Botulinum toxin type A in experimental neuropathic pain
Journal of Neural Transmission, 2005A peripheral application of botulinum toxin type A (7 U/kg) has significantly reduced thermal and mechanical hypersensitivity in rats with the partial sciatic nerve transection as a classical model of surgical neuropathy.
Zdravko Lacković+2 more
openaire +4 more sources
Observations on the Type A Toxin of Clostridium botulinum
Nature, 1951THE recent communication by Wentzel, Sterne and Polson1 makes it desirable to record some supplementary observations made in the chemical investigation of a number of toxins, especially that produced by Clostridium botulinum Type A. In the present experiments, the toxicity was determined by intraperitoneal injection into white mice of 20 gm. weight.
openaire +3 more sources
Botulinum Toxin Type A: Evaluation of Onset and Satisfaction
Plastic Surgical Nursing, 2018With the increasing interest in nonsurgical cosmetic procedures, this research study sought to evaluate the onset of Botulinum toxin Type A (BoNTA) between naive and non-naive consumers and its effect on satisfaction. This single-blinded research study consisted of 15 adults with scheduled appointments for neurotoxin treatment of undesired glabellar ...
Gregory Alouf, Erin Alouf, Tina Murphy
openaire +3 more sources
Botulinum toxin type A (BOTOX) for treatment of migraine
Seminars in Cutaneous Medicine and Surgery, 2001An open-label study and 2 double-blind, placebo-controlled studies have provided supporting evidence of botulinum toxin type A (BTX-A) as an effective, well-tolerated treatment for migraine. Observed durations of benefit were consistent with known properties of BTX-A.
Mitchell F. Brin+3 more
openaire +5 more sources
Movement Disorders, 1993
AbstractFifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after injection in all 15 patients.
Stanley Fahn, Paul E. Greene
openaire +3 more sources
AbstractFifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after injection in all 15 patients.
Stanley Fahn, Paul E. Greene
openaire +3 more sources
Journal of the American Academy of Dermatology, 2005
Alastair Carruthers, Jean Carruthers
openaire +3 more sources
Alastair Carruthers, Jean Carruthers
openaire +3 more sources
The cosmetic uses of Botulinum toxin type A
International Journal of Dermatology, 1999Anthony V. Benedetto, . Do
openaire +3 more sources